Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141395 |
| CAS No | NA |
| Mol.F. | C9H10BrClN4O |
| Mol.Wt. | 305.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141396 |
| CAS No | NA |
| Mol.F. | C12H13ClN4O2 |
| Mol.Wt. | 280.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141397 |
| CAS No | NA |
| Mol.F. | C28H37N9O4 |
| Mol.Wt. | 563.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141398 |
| CAS No | NA |
| Mol.F. | C27H33N9O5 |
| Mol.Wt. | 563.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141399 |
| CAS No | NA |
| Mol.F. | C9H13N5O |
| Mol.Wt. | 207.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141400 |
| CAS No | NA |
| Mol.F. | C16H12N4O4 |
| Mol.Wt. | 324.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141401 |
| CAS No | NA |
| Mol.F. | C17H13N3O4 |
| Mol.Wt. | 323.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141402 |
| CAS No | NA |
| Mol.F. | C14H12N2O2 |
| Mol.Wt. | 240.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141403 |
| CAS No | NA |
| Mol.F. | C29H20N4O3 |
| Mol.Wt. | 472.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141404 |
| CAS No | NA |
| Mol.F. | C23H23BrN4O4 |
| Mol.Wt. | 499.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141405 |
| CAS No | NA |
| Mol.F. | C23H23BrN4O4 |
| Mol.Wt. | 499.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141406 |
| CAS No | NA |
| Mol.F. | C9H7N3O4 |
| Mol.Wt. | 221.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141407 |
| CAS No | NA |
| Mol.F. | C11H12N4O3 |
| Mol.Wt. | 248.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141408 |
| CAS No | NA |
| Mol.F. | C16H13N3O4 |
| Mol.Wt. | 311.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141409 |
| CAS No | NA |
| Mol.F. | C18H18N4O3 |
| Mol.Wt. | 338.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141410 |
| CAS No | NA |
| Mol.F. | C11H12N4O3 |
| Mol.Wt. | 248.2 |
| INV STATUS | CUSTOM SYNTHESIS |